BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6196502)

  • 21. [Mycosis fungoides].
    Graciansky PD; Guilaine J
    Ann Med Interne (Paris); 1975 Mar; 126(3):161-9. PubMed ID: 123718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte-epidermis interactions in malignant epidermotropic lymphomas: I. Ultrastructural aspects.
    Schmitt D; Thivolet J
    Acta Derm Venereol; 1980; 60(1):1-11. PubMed ID: 6153827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis of mycosis fungoides and Sézary's syndrome by morphometric analysis of lymphoid cells in the skin.
    Meijer CJ; van der Loo EM; van Vloten WA; van der Velde EA; Scheffer E; Cornelisse CJ
    Cancer; 1980 Jun; 45(11):2864-71. PubMed ID: 6966534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sea-blue histiocytes in a patient with mycosis fungoides].
    Allegue F; Soria C; Escribano L; Rocamora A; Moreno R; Ledo A
    Med Cutan Ibero Lat Am; 1990; 18(2):141-4. PubMed ID: 2214943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
    Schappell DL; Alper JC; McDonald CJ
    Arch Dermatol; 1995 Mar; 131(3):307-13. PubMed ID: 7887660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
    Meissner K; Löning T; Rehpenning W
    In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
    Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
    Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary observations on the phenotypes of lymphoid cells in mycosis fungoides using anti-human-thymocyte monoclonal antibodies.
    Liu J; Shi Y; Kong Q; Zhang Q; Huang J; Zeng X; Wang X; Li J; Sang H; Li A
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(4):186-7. PubMed ID: 2293225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sea-blue histiocytes in mycosis fungoides.
    Robinowitz B; Roenigk HH; Smith MM
    Arch Dermatol; 1975 Sep; 111(9):1165-7. PubMed ID: 1167049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
    Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
    Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
    Imai S; Burg G; Braun-Falco O
    Dermatologica; 1986; 173(3):131-5. PubMed ID: 3770259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
    Payne CM
    Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
    [No Abstract]   [Full Text] [Related]  

  • 40. [Unilesional plaque-type mycosis fungoides: 3 cases].
    Verret JL; Rousselet MC; Peria P
    Ann Dermatol Venereol; 1997; 124(8):527-30. PubMed ID: 9740844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.